- Home
- CURI vs VOR Comparison
CURI vs VOR Comparison
Compare CURI & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURI
- VOR
- Stock Information
- Founded
- CURI N/A
- VOR 2015
- Country
- CURI United States
- VOR United States
- Employees
- CURI N/A
- VOR N/A
- Industry
- CURI Movies/Entertainment
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- CURI Consumer Discretionary
- VOR Health Care
- Exchange
- CURI Nasdaq
- VOR Nasdaq
- Market Cap
- CURI 144.8M
- VOR 85.7M
- IPO Year
- CURI N/A
- VOR 2021
- Fundamental
- Price
- CURI $5.08
- VOR $0.17
- Analyst Decision
- CURI Strong Buy
- VOR Buy
- Analyst Count
- CURI 2
- VOR 7
- Target Price
- CURI $5.40
- VOR $7.83
- AVG Volume (30 Days)
- CURI 943.7K
- VOR 1.6M
- Earning Date
- CURI 05-06-2025
- VOR 05-20-2025
- Dividend Yield
- CURI 2.85%
- VOR N/A
- EPS Growth
- CURI N/A
- VOR N/A
- EPS
- CURI N/A
- VOR N/A
- Revenue
- CURI $54,223,000.00
- VOR N/A
- Revenue This Year
- CURI $14.45
- VOR N/A
- Revenue Next Year
- CURI $10.55
- VOR N/A
- P/E Ratio
- CURI N/A
- VOR N/A
- Revenue Growth
- CURI N/A
- VOR N/A
- 52 Week Low
- CURI $0.98
- VOR $0.15
- 52 Week High
- CURI $5.30
- VOR $1.87
- Technical
- Relative Strength Index (RSI)
- CURI 78.21
- VOR 17.26
- Support Level
- CURI $3.21
- VOR $0.13
- Resistance Level
- CURI $5.30
- VOR $0.85
- Average True Range (ATR)
- CURI 0.37
- VOR 0.06
- MACD
- CURI 0.18
- VOR -0.05
- Stochastic Oscillator
- CURI 90.27
- VOR 5.77
About CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions, and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.